Duarte, CA, USA
Dr. Mingye Feng’s laboratory at the Beckman Research Institute of City of Hope Comprehensive Cancer Center is looking for talented and highly motivated Postdoctoral Fellows. Founded in 1913, City of Hope (COH) is one of only 51 National Cancer Institute-designated Comprehensive Cancer Centers in the nation and a founding member of the National Comprehensive Cancer Network (NCCN). Research performed at COH has fundamentally expanded the world’s understanding of serious diseases, such as cancer and diabetes. City of Hope was named the 11th best cancer hospital in the nation and No. 1 in the west in 2019, by US News & World Report.
Dr. Feng is an awardee of numerous awards including the V Scholar Award from the V Foundation for Cancer Research, the Damon Runyon – Dale F. Frey Award for Breakthrough Scientists from the Damon Runyon Cancer Research Foundation, and the K99/R00 Pathway to Independence Award from NIH. His laboratory employs cutting-edge techniques to understand mechanisms of macrophages in cancer immunosurveillance, identify immune checkpoints and ligands on various hematopoietic malignant and solider tumor cells with high-throughput screening and protein engineering approaches developed in the lab, and develop novel cancer immunotherapies targeting metastatic cancer cells. Cancer immunotherapy is one of the most important breakthroughs in the development of cancer treatment approaches. As one of the largest populations of immune cells in human body and the major components of primary tumors and the metastatic sites, macrophages are potentially key effectors mediating tumor immunosurveillance and thus macrophage-based cancer immunotherapy is one of the most promising fields in cancer immunology and the next generation of cancer immunotherapy.
More information regarding Dr. Feng’s laboratory (research, publications, etc.) can be found at https://www.cityofhope.org/mingye-feng
The successful candidate will utilize a combination of in vitro cell biological, molecular biological and immunological assays, large-scale high-throughput screening approaches (CIRSPR screen, drug screen, etc.) and in vivo models to study interactions between cancer cells and macrophages and develop strategies to enable macrophage-mediated cancer immunotherapies. Translational medicine is highly promoted at City of Hope. The successful candidate will have the opportunity to collaborate with clinicians at the Helford Clinical Research Hospital at City of Hope to translate research work in the laboratory to clinically viable agents and therapies. The position is available immediately with competitive salary and benefits.
The ideal candidate should have strong background in cell biology, cancer biology and immunology, excellent verbal and written skills and integral working ethics. Please contact Dr. Feng (email@example.com) with your CV and a cover letter.